Healthy Skepticism Library
Items where at least one author is a Healthy Skepticism member
HSL19675
Hagan K
Ethical fears over Pfizer deal with pharmacists
The Sydney Morning Herald 2011 Oct 20
http://www.smh.com.au/national/health/ethical-fears-over-pfizer-deal-with-pharmacists-20111019-1m817.html
HSL19068
Lacasse JR, Leo J
Knowledge of ghostwriting and financial conflicts-of-interest reduces the perceived credibility of biomedical research
BMC Research Notes 2011 Jan 31;4:27
http://www.biomedcentral.com/1756-0500/4/27/abstract
HSL19262
Ramos J
Spotlight on Industry Ties of Health Advocacy Groups
Health Watch 2011 Jan 17
http://healthwatched.org/
HSL19163
Othman N, Vitry AI, Roughead EE, Ismail SB, Omar K
Medicines information provided by pharmaceutical representatives: a com parative study in Australia and Malaysia.
BMC Public Health 2010 Nov 30;10:(1):743
http://www.biomedcentral.com/1471-2458/10/743
HSL18773
Spurling GK, Mansfield PR, Montgomery BD, Lexchin J, Doust J, Othman N, Vitry AI
Information from Pharmaceutical Companies and the Quality, Quantity, and Cost of Physicians' Prescribing: A Systematic Review
PLoS Med 2010 Oct 19;7:(10):
http://www.plosmedicine.org/article/info:doi/10.1371/journal.pmed.1000352
HSL17794
Carmody D, Mansfield PR
What do medical students think about pharmaceutical promotion?
Australian Medical Student Journal 2010 Apr;1:(1):54-7
http://www.amsj.org/archives/300
HSL17234
Othman N, Vitry AI, Roughead EE
Medicines information in medical journal advertising in Australia, Malaysia and the United States: A comparative cross-sectional study
Southern Med Review 2010;3:(1):
http://www.fmhs.auckland.ac.nz/sop/smr/_docs/SMR_Vol3_ Issue1.pdf
HSL17494
Vitry A
Reporting of Studies on New Medicines in Major Medical Journals: A Case Study in Breast Cancer
Clinical Pharmacology & Therapeutics 2010;87:(4):398–400
http://www.nature.com/clpt/journal/v87/n4/abs/clpt2009278a.html
HSL17200
Vitry AI.
Does direct-to-consumer prescription drug advertising do more harm than good?
Ann Intern Med 2009 Dec 1;151:(11):823-4
http://www.annals.org/content/151/11/823.4.long
HSL16779
Gérvas J, Wright J
Please may we have an RCT now?
BMJ 2009 Nov 10;339:
http://www.bmj.com/cgi/content/extract/339/nov10_1/b4651?papetoc
HSL16600
Vitry A
Why the ban on prescription medicine ads is a joke
Crikey 2009 Oct 7
http://www.crikey.com.au/2009/10/07/ban-on-prescription-medicine-advertising-is-a-joke/
HSL16831
Lexchin J, O'Donovan O
Prohibiting or ‘managing’ conflict of interest? A review of policies and procedures in three European drug regulation agencies
Social Science & Medicine 2009 Sep 24;
http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6VBF-4X9G8VC-2&_user=8303832&_coverDate=09/24/2009&_alid=1114653813&_rdoc=1&_fmt=high&_orig=search&_cdi=5925&_sort=r&_docanchor=&view=c&_ct=1&_acct=C000000593&_version=1&_urlVersion=0&_userid=8303832&md5=55e3d0f54e165f8c4f2281a43b85dc33
HSL16586
Gagnon MA
Recherche médicale: la belle affaire! - Medical Research: A Beautiful Business!
Le Devoir 2009 Sep 4
http://www.ledevoir.com/2009/09/04/265495.html
HSL16173
Jureidini J, Raven M.
Unpicking claims in the media about suicide and depression
Croakey: The Crikey Health Blog 2009 Aug 4
http://www.crikey.com.au/2009/08/04/unpicking-claims-in-the-media-about-suicide-and-depression/
HSL16146
Jureidini J, Clothier R.
Elsevier should divest itself of either its medical publishing or pharmaceutical services division
Lancet 2009 Aug 1;374:(9687): 375
http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(09)61404-5/fulltext
HSL16057
Othman N, Vitry A, Roughead EE.
Quality of Pharmaceutical Advertisements in Medical Journals: A Systematic Review
PLoS One 2009 Jul 22;4:(7):
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2709919
HSL16127
Swanson RC, Mosley H, Sanders D, Egilman D, De Maeseneer J, Chowdhury M, Lanata CF, Dearden K, Bryant M.
Call for global health-systems impact assessments.
Lancet 2009 Aug 8;374:(9688):433-435. Epub 2009 Jul 2
http://linkinghub.elsevier.com/retrieve/pii/S0140-6736(09)61212-5
HSL15894
Chan J, Kliner M, Currie J.
Preserving objectivity in medical education
Lancet 2009 Jun 27;373:(9682):2197
http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(09)61186-7/fulltext
HSL15685
Mansfield PR.
Under the influence
ABC Unleashed 2009 May 25
http://www.abc.net.au/unleashed/stories/s2579404.htm
HSL16112
Biron P, Mintzes B, Lexchin J, Gagnon M-A, Wright JM, Hofmann A, Musini V.
IS THE DIOVANTAGE® PATIENT SUPPORT PROGRAM DIRECT-TO-CONSUMER ADVERTISING?
Can J Clin Pharmacol 2009 May 13;16:(2):285-286
http://www.cjcp.ca/pdf/CJCP08045_e285-e286.pdf
HSL15310
Leo J, Lacasse JR.
Clinical Trials of Therapy versus Medication: Even in a Tie, Medication wins
BMJ 2009 Mar 5;Rapid response
http://www.bmj.com/cgi/eletters/338/feb05_1/b463#211098
HSL15375
Light DW
Advanced Market Commitments: Current Realities and Alternate Approaches
: HAI 2009 Mar
http://www.haiweb.org/31032009/27%20Mar%202009%20AMC%20Current%20Realities%20&%20Alternate%20Approaches%20FINAL.pdf
HSL15107
Vitry A, Gilbert A, Mott K, Rao D, March G.
Provision of medicines information in Australian community pharmacies
Pharm World Sci 2009 Feb 20;epub ahead of print
http://www.springerlink.com/content/j6l166m703610185/?p=96bb08359f8e49c8a31a8d872de5ceea&pi=0
HSL15116
Vitry A, Lai YH.
Advertising of antihypertensive medicines and prescription sales in Australia
Internal Medicine Journal 2009 Feb 16;epub ahead of print
http://www3.interscience.wiley.com/journal/122205036/abstract
HSL15153
Gérvas J.
Trastornos mentales menores en Atención Primaria. La visión con un antropólogo marciano
Equipo CESCA 2009 Feb 11
http://www.equipocesca.org/actividades-preventivas/trastornos-mentales-menores-en-atencion-primaria-la-vision-con-una-antropologo-marciano/
HSL15016
Harvey K.
Daft or draft TGA weight loss claim guidelines?
Crikey 2009 Feb 10
http://www.crikey.com.au/Politics/20090210-Daft-or-draft-TGA-weight-loss-claim-guidelines-.html
HSL15262
Leo J, Lacasse JR.
Consumer advertisements of medications for ADHD
Tamimi S, Leo J. Rethinking ADD: From Brain To Culture. New York: Palgrave Macmillan 2009
http://www.amazon.com/Rethinking-ADHD-Culture-Sami-Timimi/dp/0230507123
HSL16024
Lexchin J.
CJEM and pharmaceutical advertisements: it’s time for an end
CJEM 2009;11:(4):375-9
http://www.cjem-online.ca/v11/n4/p375
HSL16459
Gérvas J, Mansfield PR
Physicians, the industry and population health
Journal of Epidemiology and Community Health 2009;63:(10):773-774
http://jech.bmj.com/cgi/content/extract/63/10/773
HSL16758
Egilman D
Just say no
BMJ 2009;339:b4527
http://www.bmj.com/cgi/content/short/339/nov02_2/b4527?rss=1
HSL17849
Villanueva T
Centro Vasco de Información de Medicamentos CEVIME-MIEZ
Rev Port Clin Geral 2009;25:724
http://www.osanet.euskadi.net/r8520361/es/ contenidos/informacion/presentacion_cevime/ es_1219/indice_c.html
HSL14648
Raven M .
Are drug companies hijacking consumer advocacy?
Crikey 2008 Nov 20
http://www.crikey.com.au/Politics/20081120-Are-drug-companies-hijacking-consumer-advocacy.html
HSL14567
Ross JS, Nazem AG, Lurie P, Lackner JE, Krumholz HM.
Updated Estimates of Pharmaceutical Company Payments to Physicians in Vermont
JAMA 2008 Nov 5;300:(17):1998-2000
http://jama.ama-assn.org/cgi/content/extract/300/17/1998-a?etoc
HSL14449
Brody H.
'Biologicals'--a Technique to Justify High Drug Prices
Hooked: Ethics, Medicine, and Pharma (blog) 2008 Oct 17
http://brodyhooked.blogspot.com/2008/10/biologicals-technique-to-justify-high.html
HSL14435
Vitry A.
Time for transparency at the TGA
Australian Prescriber 2008 Oct;31:114-6
http://www.australianprescriber.com/magazine/31/5/114/6/
HSL14154
Hill KP, Ross JS, Egilman DS, Krumholz HM.
The ADVANTAGE seeding trial: a review of internal documents.
Annals of Internal Medicine 2008 Aug 19;149:(4):251-8
http://www.annals.org/cgi/content/full/149/4/251
HSL14068
Harvey K.
Is regulation of complementary medicine marketing a joke?
Crikey 2008 Jul 29
http://web.archive.org/web/20090401203403/http://www.crikey.com.au/Blogs/Croakey/Is-regulation-of-complementary-medicine-marketing-a-joke.html
HSL13994
Brody H.
PhRMA Code in Action in Massachusetts: Behind the Scenes
Hooked: Ethics, Medicine, and Pharma (blog) 2008 Jul 18
http://brodyhooked.blogspot.com/2008/07/phrma-code-in-action-in-massachusetts.html
HSL13958
Brody H.
New PhRMA Code, I: Defending the Line
Hooked: Ethics, Medicine, and Pharma (blog) 2008 Jul 12
http://brodyhooked.blogspot.com/2008/07/new-phrma-code-i-defending-line.html
HSL13959
Brody H.
New PhRMA Code, II: The Larger Context
Hooked: Ethics, Medicine, and Pharma (blog) 2008 Jul 12
http://brodyhooked.blogspot.com/2008/07/new-phrma-code-ii-larger-context.html
HSL14211
Othman N.
Iklan ubat-ubatan di jurnal perubatan - Informasi yang diragui? [Pharmaceutical advertisements in medical journals : poor quality of information?]
Dewan Kosmik 2008 Jul
HSL14605
McHenry LB, Jureidini JN.
Industry-sponsored ghostwriting in clinical trial reporting: a case study.
Account Res 2008 Jul-Sep;15:(3):152-67
http://www.ncbi.nlm.nih.gov/pubmed/18792536
HSL13794
Gérvas J.
Human papillomavirus vaccines. Three decent proposals .
CMAJ 2008 Jun 13;epub
http://www.cmaj.ca/cgi/eletters/177/12/1527
HSL13856
Lexchin J, Basset K, Biron P, Mansfield PR, Mintzes B.
Medications for obesity
Can Fam Physician 2008 Jun;54:(6):848 - 849
http://www.cfp.ca/cgi/content/full/54/6/848-a?etoc
HSL14069
Lexchin J.
Doctors and Industry Funding of Continuing Medical Education: Guilty as Charged
The Israeli Journal of Emergency Medicine 2008 Jun;8:(2):23-25
http://isrjem.org/Isrjem_June08.Funding%20Lexchin_Postprod.pdf
HSL13620
Montgomery BD.
Free lunches are not the answer
BMJ 2008 May 10;336:(7652):1034
http://www.bmj.com/cgi/content/full/336/7652/1034-b?ijkey=XMbLfmtZum7YhNt&keytype=ref
HSL13569
Jureidini JN, McHenry LB, Mansfield PR.
Clinical trials and drug promotion: Selective reporting of study 329
The International Journal of Risk and Safety in Medicine 2008 May;20:(1-2):73-81
http://iospress.metapress.com/content/k36834543w9063rr/?p=8b89494c5d4c4f42946f75de3efdefa1&pi=6
HSL13535
Ross JS, Hill KP, Egilman DS, Krumholz HM.
Guest authorship and ghostwriting in publications related to rofecoxib: a case study of industry documents from rofecoxib litigation.
JAMA 2008 Apr 16;299:(15):1800-12
http://jama.ama-assn.org/cgi/content/full/299/15/1800
HSL13869
Egilman DS, Bohme SR.
IJOEH and the critique of bias.
Int J Occup Environ Health 2008 Apr-Jun;14:(2):147-51
http://www.ncbi.nlm.nih.gov/pubmed/18507293
HSL14474
Light DW, Warburton RN.
Ethical Standards for Healthcare Journal Editors: A Case Report and Recommendations
Harvard Health Policy Review 2008 Spring;9:(1):46-55
http://www.hhpr.org/currentissue/archives.php
HSL13128
Vitry A, Lexchin J, Sasich L, Dupin-spriet T, Reed T, Bertele V, Garattini S, Toop L, Hurley E.
Provision of information on regulatory authorities’ websites
Internal Medicine Journal 2008 Mar 11;epub ahead of print
http://www.blackwell-synergy.com/doi/abs/10.1111/j.1445-5994.2007.01588.x
HSL13194
De Maeseneer J, Van Weel C, Egilman D, Mfenyana K, Kaufman A, Sewankambo N, Flinkenflögel M.
Funding for primary health care in developing countries
BMJ 2008 Mar 8;336:(7643):518
http://www.bmj.com/cgi/content/extract/336/7643/518
HSL13001
Othman N.
Promosi ubat-ubatan: Adakah keuntungan mengaburi kualiti informasi? [Pharmaceutical promotion: Does the drive for profits reduce the quality of information?]
Dewan Kosmik 2008 Mar25-26
HSL12731
Jutel A, Menkes DB.
Soft Targets: Nurses and the Pharmaceutical Industry
PLoS Medicine 2008 Feb 5;5:(2):5
http://medicine.plosjournals.org/perlserv/?request=get-document&doi=10.1371/journal.pmed.0050005
HSL12949
Herxheimer A, Sanz E.
Social, cultural and ethical aspects of drug use—changes over 40 years: a personal look back
European Journal of Clinical Pharmacology 2008 Feb;64:(2):107-114
http://www.springerlink.com/content/u2rn52n6x15x71h6/fulltext.html
HSL12275
Mansfield PR.
Do advertisements in clinical software influence prescribing?
Med J Aust 2008 Jan 7;188:(1):13-14
http://www.mja.com.au/public/issues/188_01_070108/man11083_fm.html
HSL12277
Harvey K, Korczak VS, Marron LJ, Newgreen DB.
Commercialism, choice and consumer protection: regulation of complementary medicines in Australia
The Medical Journal of Australia 2008;188:(1):21-25
http://www.mja.com.au/public/issues/188_01_070108/har10522_fm.html
HSL13686
Lexchin J.
Drug Approval Times and User Fees: An International Perspective in a Changing World
Pharm Med 2008;22:(1):1-11
http://www.ingentaconnect.com/content/adis/ipm
HSL13687
Cassels A, Lexchin J.
How well do Canadian media outlets convey medical treatment information?
Open Medicine 2008;2:(2):epub
http://www.openmedicine.ca/article/view/170/131
HSL12119
Jureidini J.
The Black Box Warning: Decreased Prescriptions and Increased Youth Suicide?
Am J Psychiatry 164:1907, December 2007 2007 Dec;164:(12):1907
http://ajp.psychiatryonline.org/cgi/content/full/164/12/1907
HSL13457
Moncrieff J.
The Myth of the Chemical Cure: A Critique of Psychiatric Drug Treatment
: Palgrave Macmillan 2007
http://www.palgrave.com/products/title.aspx?PID=283272
HSL12115
Leo J, Lacasse JR.
The Media and the Chemical Imbalance Theory of Depression
Society 2007 Nov 28;epub ahead of print
http://www.springerlink.com/content/u37j12152n826q60/fulltext.html
HSL11879
Bala-Miller P, Macmullan J, Upchurch L
Drugs, doctors and dinners: How drug companies influence health in the developing world
London: Consumers International 2007 Oct 31
http://web.archive.org/web/20080908164330/http://marketingoverdose.org/documents/ci_pharma_2007.pdf
HSL13186
Nordin C.
The pharmaceutical industry and doctors' prescribing habits
Ockham's Razor (Radio National, Australian Broadcasting Commission) 2007 Oct 14
http://www.abc.net.au/rn/ockhamsrazor/stories/2007/2056879.htm
HSL11658
Toop L, Mangin D.
Industry funded patient information and the slippery slope to New Zealand
BMJ 2007 Oct 6;335:(7622):694
http://www.bmj.com/cgi/content/short/335/7622/694?etoc
HSL11774
Vitry A, Lexchin J, Mansfield PR.
Is Australia's National Medicines Policy Failing? The Case of Cox-2 Inhibitors
Int J Health Serv 2007 Oct;37:(4):735 - 744
http://baywood.metapress.com/app/home/contribution.asp?referrer=parent&backto=issue,9,13;journal,1,148;linkingpublicationresults,1:300313,1
HSL11838
Light D.
Misleading Congress about Drug Development
Journal of Health Politics, Policy and Law 2007 Oct;32:(5):895-913
http://web.archive.org/web/20090610012035/http://www.bioethics.upenn.edu/People/?last=Light&first=Donald
HSL11573
Allan GM, Lexchin J, Wiebe N.
Physician Awareness of Drug Cost: A Systematic Review
PLoS Med 2007 Sep 25;4:(9):e283
http://medicine.plosjournals.org/perlserv/?request=get-document&doi=10.1371/journal.pmed.0040283
HSL11468
Egilman D.
The Truth Is Not Free
The Pump Handle 2007 Sep 11
http://thepumphandle.wordpress.com/2007/09/11/the-truth-is-not-free/
HSL11411
Norsigian J, Stephenson H.
HPV Vaccine Flags Need for More Pap Tests
Women's eNews 2007 Sep 5
http://www.womensenews.org/article.cfm?aid=3303
HSL11393
Mansfield P.
Xenical, the drug that dare not speak its name
Crikey 2007 Sep 3
http://www.crikey.com.au/Politics/20070903-Regulatory-spat-over-pill-for-the-fat.html
HSL11477
Vitry A, Mintzes B, Lexchin J
Direct-to-consumer advertising policy in Australia: realism in whose interests?
Internal Medicine Journal 2007 Sep;37:(9):665–666
http://www.blackwell-synergy.com/doi/abs/10.1111/j.1445-5994.2007.01447.x
HSL12152
Lexchin J.
The secret things belong unto the Lord our God: secrecy in the pharmaceutical arena.
Med Law 2007 Sep;26:(3):417-30
http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=Retrieve&db=PubMed&list_uids=17970243
HSL11379
Mansfield P.
Pharma pays the piper: will Roche call Kidney Health Australia’s tune?
Crikey 2007 Aug 28
http://www.crikey.com.au/Politics/20070827-Pharma-pays-the-piper-Will-Roche-call-Kidney-Health-Australias-tune.html
HSL11253
Menkes DB, Jureidini JN, Mansfield PR.
Skepticism about antidepressants for under 18s
BMJ Rapid Response 2007 Aug 22;epub
http://www.bmj.com/cgi/eletters/335/7615/329#175023
HSL11156
Mangin D, Sweeney K, Heath I.
Preventive health care in elderly people needs rethinking
BMJ 2007 Aug 11;335:(7614):285
http://www.bmj.com/cgi/content/full/335/7614/285
HSL11242
Spurling G, Mansfield P.
General practitioners and pharmaceutical sales representatives: quality improvement research.
Qual Saf Health Care 2007 Aug;16:(4):266-70
http://qshc.bmj.com/content/16/4/266.abstract
HSL10983
Biles D, Howlett P, Hughes R.
Journals and drug advertising: Medical schools, take the lead
BMJ 2007 Jul 28;335:(7612):172
http://www.bmj.com/cgi/content/full/335/7612/172-a
HSL11057
Light DW.
Is G8 putting profits before the world's poorest children?
The Lancet 2007 Jul 28;370:(9584):297-298
http://www.thelancet.com/journals/lancet/article/PIIS0140673607611386/fulltext
HSL10587
Jureidini JN.
Not a trial of antidepressants
BMJ 2007 Jun 18;epub
http://www.bmj.com./cgi/eletters/bmj.39224.494340.55v1
HSL10449
Harvey K.
Conduct becoming? GPs' GlaxoSmithKline degustation
Crikey 2007 Jun 14
http://www.crikey.com.au/Politics/20070614-Why-doctors-love-the-good-life.html
HSL10437
Harvey KJ, Harris AH, Bulfone L.
The National Health Amendment (Pharmaceutical Benefits Scheme) Bill 2007: reform or fracture?
Med J Aust 2007 Jun 13;187:(4):206-207
http://www.mja.com.au/public/issues/187_04_200807/har10641_fm.html
HSL11711
Faunce TA, Lexchin J.
'Linkage' pharmaceutical evergreening in Canada and Australia.
Aust New Zealand Health Policy 2007 Jun 1;4:(1):8
http://www.anzhealthpolicy.com/content/4/1/8
HSL10209
Norsigian J.
Misleading Ads and How They Hurt Us
The Women's Media Center 2007 May 25
http://www.womensmediacenter.com/ex/052207.html
HSL10092
Mansfield PR.
The illusion of invulnerability
BMJ 2007 May 19;334:(7602):1020
http://www.bmj.com/cgi/content/full/334/7602/1020-c
HSL9978
Mansfield PR.
The illusion of invulnerablity
BMJ 2007 May 6;334:(7600):epub
http://www.bmj.com/cgi/eletters/334/7600/934#164939
HSL9351
Harvey K.
Schwabe Pharma Australia & Natural Health Products - litigation update
AusPharmList (subscription required) 2007 Apr 5
http://www.auspharmlist.net.au/post.php?postid=9858
HSL10077
Cheng AC, Robinson PM, Harvey K.
Off-label use of medicines: consensus recommendations for evaluating appropriateness.
Med J Aust 2007 Apr 2;186:(7):379-80
http://www.mja.com.au/public/issues/186_07_020407/letters_020407_fm-2.html
HSL13327
Roy N, Madhiwalla N, Pai SA.
Drug promotional practices in Mumbai: a qualitative study
Indian Journal of Medical Ethics 2007 Apr-Jun;4:(2):57-61
http://www.ijme.in/152oa57.html
HSL9813
Menkes DB, Maharajh M.
Just saying 'no' to pharmaceutical sponsorship
N Z Med J 2007 Mar 23;120:(1251):U2471
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&list_uids=17384699&query_hl=13&itool=pubmed_DocSum
HSL10784
Rogers , W.a.
The tangled web of medical and commercial interests
Health Expectations 2007 Mar;10:(1):1-3
HSL11980
Spurling G, Kyle G.
Is your sample cupboard relevant to your practice?
Aust Fam Physician 2007 Mar;36:(3):187-8,
http://www.racgp.org.au/Content/NavigationMenu/Publications/AustralianFamilyPhys/2007issues/afp200703/200703spurling.pdf
HSL8737
Mansfield PR, Hoffman JR, Lexchin J.
Educating Health Professionals about Drug and Device Promotion: Authors' Reply.
PLoS Med. 2007 Feb 27;4:(2):e88
http://medicine.plosjournals.org/perlserv/?request=get-document&doi=10.1371/journal.pmed.0040088
HSL8602
Harvey K.
Medicines Australia latest Code of Conduct Report
AusPharmList 2007 Feb 16
http://auspharmlist.net.au/post.php?postid=9292
HSL11005
Moncrieff J.
In Debate: Are Antidepressants as Effective as Claimed? No, They Are Not Effective at All
Can J Psychiatry 2007 Feb;52:(2):96–97
http://publications.cpa-apc.org/media.php?mid=328
HSL7570
Krumholz HM, Hines HH, Ross JS, Presler AH, Egilman DS.
What have we learnt from Vioxx?
BMJ 2007 Jan 20;334:(7585):120
http://www.bmj.com/cgi/content/full/334/7585/120
HSL9983
Lexchin J.
Of Money and Trust in Biomedical Care
Mens Sana Monographs 2007 Jan-Dec;5:(1):7-10
http://www.msmonographs.org/article.asp?issn=0973-1229;year=2007;volume=5;issue=1;spage=7;epage=10;aulast=Lexchin
HSL10023
Guyatt G, Devereaux PJ, Lexchin J, Stone SB, Yalnizyan A, Himmelstein D, Woolhandler S, Zhou Q, Goldsmith G, Cook DJ, Haines T, Lacchetti C, Lavis J, Sullivan T, Mills E, Kraus S, Bhatnagar N.
A systematic review of studies comparing health outcomes in Canada and the United States
Open Medicine 2007;1:(1):E27-36
http://www.openmedicine.ca/article/view/8/1
HSL8520
Lexchin J.
A comparison of new drug availability in Canada and the United States and potential therapeutic implications of differences.
Health Policy 2006 Dec;79:(2-3):214-20
http://linkinghub.elsevier.com/retrieve/pii/S0168-8510(06)00003-0
HSL8517
Mansfield PR.
Doctors as lapdogs to drug firms: Independence may be most cost effective way to improve health care.
BMJ 2006 Nov 25;333:(7578):1121-2
http://www.bmj.com/cgi/content/full/333/7578/1121-c
